These folks are grilled about the data by upper management and all aspects of the program (trial design, data analysis, adverse events, etc.) are reviewed.

FORBES: Why Was Bapi Moved Into Phase 3 Clinical Trials?

What we need is a construct with teeth, an established network of industry-independent researchers (not contractors) equipped to evaluate trial design, statistical power, data analysis, and interpretation, not as regulators but as contributors to final research publications.

FORBES: How Can Big Pharma Restore A Reputation?

According to the lead author, Dr. Paul Ridker of the Brigham and Women's Hospital in Boston, Massachusetts, the pharmaceutical company had no input in the study's design and didn't see the final data analysis until the study was submitted for publication.

CNN: Study: Cholesterol drugs could help those with healthy levels